Global Physician Dispensed Cosmeceuticals Market Size, Share, Growth Analysis, By Product Type(Skin Care, Hair Care), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2023-2030

Inquiry

I acknowledge that I have read the Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

License Type Top market research company in USA

File Type

Analyst Support

$5,300

BUY NOW GET SAMPLE

FAQ's

Physician Dispensed Cosmeceuticals Market was valued at USD 8.5 Billion in 2021, and USD 9.16 billion in 2022 and it is expected to reach a value of USD 16.7 Billion by 2030, at a CAGR of 7.8% over the forecast period (2023 - 2030).

The Global Physician Dispenced Cosmeceuticals market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses in order to increase market share and profitability. Due to the existence of numerous small and major producers, the market is somewhat competitive. Due to increased expenditures in R&D for product innovation and boosting product efficiency by bringing new items into the market, the market rivalry is fierce. Allergan, Merz Pharma, INNOVATIVE SKINCARE, Obagi Cosmeceuticals LLC, SkinCeuticals International, and others are key participants in the industry. 'Allergan Plc', 'SkinMedica, Inc.', 'Biopelle, Inc.', 'Clinique Laboratories, LLC', 'Cutera, Inc.', 'Emerson Ecologics, LLC', 'iS CLINICAL', 'Jan Marini Skin Research, Inc.', 'La Roche-Posay Laboratoire Pharmaceutique', 'Neutrogena Corp.', 'Obagi Medical Products, Inc.', 'SkinCeuticals', 'Stiefel Laboratories, Inc.'

The need for cosmeceuticals to eliminate visible aging indications is driven by a rise in personal maintenance awareness among the elderly population and changing views among the middle-aged and aging population in emerging nations.

SkinCeuticals, a pioneer in breakthrough skincare technologies, will launch Vivace Fractional Micro Needle Radio Frequency Procedure with SkinCeuticals C E Ferulic in October 2020, a minimally invasive skin rejuvenation treatment.

North America, Europe, Asia Pacific, and the Rest of the World make up the Global Physician Dispensed Cosmeceuticals Market. Over the projected period, the Asia Pacific market is predicted to increase considerably. In the area, there is a growing desire to see long-lasting young appearance and beauty, which is driving the demand for effective physician-dispensed cosmeceuticals. Furthermore, the Asia Pacific market will be driven by leading market players' increasing focus on expansion in Asia Pacific nations, the region's large consumer base, and increased awareness of physician-dispensed cosmeceuticals.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Physician Dispensed Cosmeceuticals Market Size, Share, Growth Analysis, By Product Type(Skin Care, Hair Care), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2023-2030

Inquiry

Confidentiality

Subscribe & Save

FAQ's

What is the global market size of Physician Dispensed Cosmeceuticals Market?

Who are the key vendors in the Global Physician Dispensed Cosmeceuticals Market?

What is the key driver of Global Physician Dispensed Cosmeceuticals Market?

What is the key market trend for Global Physician Dispensed Cosmeceuticals Market?

Which region accounted for the largest share in Global Physician Dispensed Cosmeceuticals Market?

Related Reports

Feedback From Our Clients

$5,300